A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry
- 1 April 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Women's Health
- Vol. 32 (4), 423-433
- https://doi.org/10.1089/jwh.2022.0133
Abstract
To compare 12-month post-treatment health-related quality of life (HR-QoL) and symptom severity (SS) changes among patients with symptomatic uterine fibroids (SUF) not seeking fertility and undergo a hysterectomy, abdominal myomectomy (AM), or uterine artery embolization (UAE). The Comparing Options for Management: Patient-Centered Results for Uterine Fibroids (COMPARE-UF) Registry is a multi-institutional prospective observational cohort study of patients treated for SUF. A subset of 1465 women 31–45 years of age, who underwent either hysterectomy (n = 741), AM (n = 446), or UAE (n = 155) were included in this analysis. Demographics, fibroid history, and symptoms were obtained by baseline questionnaires and at 1 year post-treatment. Results were stratified by all treatments and propensity score weighting to adjust for differences in baseline characteristics. Women undergoing UAE reported the lowest baseline HR-QoL and highest SS scores (mean = 40.6 [standard deviation (SD) = 23.8]; 62.3 [SD = 24.2]) followed by hysterectomy (44.3 [24.3]; 59.8 [SD = 24.1]). At 12 months, women who underwent a hysterectomy experienced the largest change in both HR-QoL (48.7 [26.2]) and SS (51.9 [25.6]) followed by other uterine-sparing treatments. Propensity score weighting revealed all treatments produced substantial improvement, with hysterectomy patients reporting the highest HR-QoL score (92.0 [17.8]) compared with myomectomy (86.7 [17.2]) and UAE (82.6 [21.5]) (p < 0.0001). Similarly, hysterectomy patients reported the lowest SS scores (8.2 [15.1]) compared with myomectomy (16.5 [15.1]) and UAE (19.6 [17.5]) (p < 0.0001). All procedures showed improvement in HR-QoL and reduction in SS score at 12 months, hysterectomy showing maximum improvement. Of importance, at 12 months, patients who underwent either a myomectomy or UAE reported comparable symptom relief and HR-QoL. Clinicaltrials.Gov Identifier: NCT02260752.This publication has 33 references indexed in Scilit:
- Further Validation of the Uterine Fibroid Symptom and Quality-of-Life QuestionnaireValue in Health, 2012
- Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year resultsBJOG: An International Journal of Obstetrics and Gynaecology, 2011
- Outcomes From Leiomyoma TherapiesObstetrics & Gynecology, 2010
- Uterine Artery Embolization versus Abdominal Myomectomy: A Long-term Clinical Outcome ComparisonJournal of Vascular and Interventional Radiology, 2010
- The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)Health and Quality of Life Outcomes, 2008
- Midterm Clinical and First Reproductive Results of a Randomized Controlled Trial Comparing Uterine Fibroid Embolization and MyomectomyCardioVascular and Interventional Radiology, 2007
- Uterine-Artery Embolization versus Surgery for Symptomatic Uterine FibroidsThe New England Journal of Medicine, 2007
- Outcome of uterine embolization and hysterectomy for leiomyomas: Results of a multicenter studyAmerican Journal of Obstetrics and Gynecology, 2004
- Comparison of long-term outcomes of myomectomy and uterine artery embolization*1Obstetrics & Gynecology, 2002
- Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomasObstetrics & Gynecology, 1996